| Classification of primary progressive aphasia and its variants ML Gorno-Tempini, AE Hillis, S Weintraub, A Kertesz, M Mendez, ... Neurology 76 (11), 1006-1014, 2011 | 5363 | 2011 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2490 | 2019 |
| Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 M Cruts, I Gijselinck, J Van Der Zee, S Engelborghs, H Wils, D Pirici, ... Nature 442 (7105), 920-924, 2006 | 1732 | 2006 |
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1637 | 2015 |
| Functional anatomy of a common semantic system for words and pictures R Vandenberghe, C Price, R Wise, O Josephs, RSJ Frackowiak Nature 383 (6597), 254-256, 1996 | 1485 | 1996 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1370 | 2022 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 965 | 2017 |
| A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene … I Gijselinck, T Van Langenhove, J van der Zee, K Sleegers, S Philtjens, ... The Lancet Neurology 11 (1), 54-65, 2012 | 790 | 2012 |
| 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial R Vandenberghe, K Van Laere, A Ivanoiu, E Salmon, C Bastin, E Triau, ... Annals of neurology 68 (3), 319-329, 2010 | 735 | 2010 |
| Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease MF Egan, J Kost, PN Tariot, PS Aisen, JL Cummings, B Vellas, C Sur, ... New England Journal of Medicine 378 (18), 1691-1703, 2018 | 684 | 2018 |
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 663 | 2015 |
| The neural systems sustaining face and proper-name processing. ML Gorno-Tempini, CJ Price, O Josephs, R Vandenberghe, SF Cappa, ... Brain: a journal of neurology 121 (11), 2103-2118, 1998 | 624 | 1998 |
| Disrupted temporal lobe connections in semantic dementia CJ Mummery, K Patterson, RJS Wise, R Vandenbergh, CJ Price, ... Brain 122 (1), 61-73, 1999 | 546 | 1999 |
| Consensus classification of posterior cortical atrophy SJ Crutch, JM Schott, GD Rabinovici, M Murray, JS Snowden, ... Alzheimer's & Dementia 13 (8), 870-884, 2017 | 531 | 2017 |
| The response of left temporal cortex to sentences R Vandenberghe, AC Nobre, CJ Price Journal of cognitive neuroscience 14 (4), 550-560, 2002 | 446 | 2002 |
| Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology J Chapuis, F Hansmannel, M Gistelinck, A Mounier, ... Molecular psychiatry 18 (11), 1225-1234, 2013 | 431 | 2013 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 406 | 2013 |
| Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease G Chételat, R La Joie, N Villain, A Perrotin, V de La Sayette, F Eustache, ... NeuroImage: Clinical 2, 356-365, 2013 | 406 | 2013 |
| Orienting attention to locations in perceptual versus mental representations AC Nobre, JT Coull, P Maquet, CD Frith, R Vandenberghe, MM Mesulam Journal of cognitive neuroscience 16 (3), 363-373, 2004 | 397 | 2004 |
| Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease N Nelissen, K Van Laere, L Thurfjell, R Owenius, M Vandenbulcke, ... Journal of Nuclear Medicine 50 (8), 1251-1259, 2009 | 350 | 2009 |
